Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SYK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A gene referenced in 1 knowledge graph relationship. Key connections: encodes SYK_kinase (protein).
| Gene Symbol | SYK |
| Chromosome | 9q22 |
| Protein Family | Src family tyrosine kinases |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | brain microglia (Iba1+ cells) - Increased expression in disease states - Localizes to amyloid plaques in AD |
| Molecular Weight | ~72 kDa |
| Amino Acids | 629 aa |
| Exons | 18 |
| Pathways | PI3K, MAPK |
| UniProt ID | P43405 |
| NCBI Gene ID | 6715 |
| GeneCards | SYK |
| Human Protein Atlas | SYK |
| Gene Name | Spleen Tyrosine Kinase |
| Associated Diseases | ALS, Alzheimer, CYTOKINES, PYROPTOSIS |
| Known Drugs/Compounds | R406, Entospletinib, Pustulan, metformin |
| Interactions | TREM2, DAP12, MTOR, AKT, NLRP3, JNK |
| KG Connections | 367 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SYK["<b>SYK</b>"]
Alzheimer{"Alzheimer"}
SYK -->|"activates"| Alzheimer
Ms{"Ms"}
SYK -->|"activates"| Ms
SYK -->|"associated with"| Alzheimer
TFEB["TFEB"]
SYK -->|"associated with"| TFEB
TREM2["TREM2"]
SYK -->|"associated with"| TREM2
Als{"Als"}
SYK -->|"interacts with"| Als
Obesity{"Obesity"}
SYK -->|"activates"| Obesity
Depression{"Depression"}
SYK -->|"expressed in"| Depression
SYK -->|"activates"| TREM2
Apoptosis(["Apoptosis"])
SYK -->|"activates"| Apoptosis
Amyloid(["Amyloid"])
SYK -->|"associated with"| Amyloid
SYK -->|"associated with"| Apoptosis
AKT["AKT"]
AKT -->|"associated with"| SYK
PI3K["PI3K"]
PI3K -->|"associated with"| SYK
APOE["APOE"]
APOE -->|"associated with"| SYK
MICROGLIA["MICROGLIA"]
MICROGLIA -->|"activates"| SYK
TREM2 -->|"expressed in"| SYK
IL6["IL6"]
IL6 -->|"expressed in"| SYK
IL1B["IL1B"]
IL1B -->|"expressed in"| SYK
IL10["IL10"]
IL10 -->|"expressed in"| SYK
TAU["TAU"]
TAU -->|"expressed in"| SYK
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| SYK
AMYLOID["AMYLOID"]
AMYLOID -->|"activates"| SYK
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
ALZHEIMER_S_DISEASE -->|"activates"| SYK
style SYK fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| HIF-1α/c-Myc | regulates | pathway | 0.95 |
| macrophage phagocytosis | regulates | process | 0.95 |
| Monocyte-Derived Macrophages | expressed_in | cell_type | 0.95 |
| Macrophage Phagocytosis | regulates | process | 0.95 |
| Functional Recovery After Spinal Cord Injury | promotes | phenotype | 0.95 |
| PI3K/AKT/mTOR | regulates | pathway | 0.95 |
| Tau Phosphorylation | regulates | process | 0.95 |
| Spinal Cord Injury | therapeutic_target | disease | 0.93 |
| AMPK/STAT3 | regulates | pathway | 0.90 |
| axonal regeneration | promotes | process | 0.90 |
| acute motor axonal neuropathy | therapeutic_target | disease | 0.90 |
| Tau Oligomerization | regulates | process | 0.90 |
| mitophagy | modulates | process | 0.90 |
| lipid metabolism | modulates | pathway | 0.90 |
| Microglia | associated_with | cell_type | 0.90 |
| locomotor recovery | promotes | phenotype | 0.89 |
| lipid droplet accumulation | regulates | phenotype | 0.87 |
| Axonal Regrowth | promotes | process | 0.85 |
| CD22 Blockade | mediates | drug | 0.80 |
| Aβ Clearance | associated_with | process | 0.80 |
| Alzheimer's Disease | involved_in | disease | 0.80 |
| Amyloid-Beta Clearance | associated_with | process | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| oxidative stress response | participates_in | pathway | 0.75 |
| pyroptosis | participates_in | pathway | 0.70 |
| PI3K/AKT PATHWAY | causes | pathway | 0.70 |
| PI3K/AKT/MTOR | causes | pathway | 0.70 |
| MICROGLIA | protects_against | cell_type | 0.70 |
| TFEB | associated_with | gene | 0.65 |
| TREM2 | associated_with | gene | 0.65 |
| STAT3 | phosphorylates | gene | 0.65 |
| STAT3 | causes | gene | 0.65 |
| TAU | phosphorylates | protein | 0.65 |
| TAU | degrades | protein | 0.65 |
| TAU | activates | protein | 0.65 |
| MTOR | transports | gene | 0.65 |
| NLRP3 | promotes | gene | 0.65 |
| TAU | inhibits | gene | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Depression | expressed_in | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Atherosclerosis | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Entospletinib | inhibits | drug | 0.95 |
| TREM2 | interacts_with | gene | 0.92 |
| Pustulan | activates | compound | 0.90 |
| h-d2937ed0 | targets_gene | hypothesis | 0.90 |
| h-trem2-f3effd21 | targets_gene | hypothesis | 0.90 |
| TREM2 | upstream_of | gene | 0.88 |
| CD22 Blockade | phosphorylates | drug | 0.85 |
| R406 | inhibits | drug | 0.85 |
| APOE | interacts_with | gene | 0.70 |
| APOE | phosphorylates | gene | 0.70 |
| TYROBP | phosphorylates | gene | 0.70 |
| TYROBP | interacts_with | gene | 0.70 |
| INFLAMMATION | therapeutic_target | gene | 0.70 |
| AKT | associated_with | gene | 0.65 |
| PI3K | associated_with | gene | 0.65 |
| APOE | associated_with | gene | 0.65 |
| CSF | interacts_with | phenotype | 0.65 |
| CSF | activates | phenotype | 0.65 |
| VCP | regulates | gene | 0.65 |
| TREM2 | inhibits | gene | 0.65 |
| TREM2 | mediates | gene | 0.65 |
| TYROBP | regulates | gene | 0.65 |
| NLRP3 | mediates | gene | 0.65 |
| VCP | phosphorylates | gene | 0.65 |
| ISCHEMIA | regulates | disease | 0.65 |
| PYROPTOSIS | regulates | phenotype | 0.65 |
| MICROGLIA | causes | cell_type | 0.65 |
| DAM | interacts_with | cell_type | 0.65 |
| DAM | activates | cell_type | 0.65 |
| NLRP3 INFLAMMASOME | regulates | pathway | 0.65 |
| NLRP3 INFLAMMASOME | degrades | pathway | 0.65 |
| MACROPHAGE | activates | cell_type | 0.65 |
| FERROPTOSIS | inhibits | phenotype | 0.65 |
| MICROGLIA | promotes | cell_type | 0.65 |
| TREM2 | expressed_in | gene | 0.60 |
| IL6 | expressed_in | gene | 0.60 |
| IL1B | expressed_in | gene | 0.60 |
| IL10 | expressed_in | gene | 0.60 |
| TAU | expressed_in | gene | 0.60 |
| DAP12 | activates | gene | 0.60 |
| TREM2 | regulates | gene | 0.60 |
| ABCA7 | regulates | gene | 0.60 |
| PPARG | regulates | gene | 0.60 |
| LPL | regulates | gene | 0.60 |
| TOLLIP | therapeutic_target | gene | 0.60 |
| AKT | phosphorylates | entity | 0.60 |
| APOE | regulates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| TNC | regulates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial TREM2-SYK Pathway Enhancement | 0.626 | neurodegeneration | Cell type vulnerability in Alzheimers Di |
| SYK-Independent TREM2 Pathways Remain Functional in TYROBP D | 0.555 | neuroinflammation | Why is TYROBP deficiency neuroprotective |
| TREM2-SYK Signaling Axis Couples OxPC Recognition to Phagocy | 0.505 | neuroinflammation | What molecular mechanisms enable microgl |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.529
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||